Interestingly, the combination of ATM deletions and SF3B1 mutations results in a CLL-like disease in elderly mice leading to genome instability, dysregulation of CLL-associated processes and providing mechanistic evidence for disease development [41]. Here, ATM is linked to B-cell chronic lymphocytic leukemia.